vs

Side-by-side financial comparison of Kimbell Royalty Partners, LP (KRP) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $82.5M, roughly 1.0× Kimbell Royalty Partners, LP). Kimbell Royalty Partners, LP runs the higher net margin — 30.1% vs -38.1%, a 68.1% gap on every dollar of revenue. On growth, Kimbell Royalty Partners, LP posted the faster year-over-year revenue change (23.6% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 0.1%).

Kimbell Royalty Partners, LP is a publicly traded US limited partnership focused on owning and acquiring mineral and royalty interests in oil and gas properties across key domestic producing basins including the Permian, Bakken, and Eagle Ford. Its core revenue comes from production-linked royalty payments from its diversified onshore hydrocarbon asset portfolio.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

KRP vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.0× larger
PRCT
$83.1M
$82.5M
KRP
Growing faster (revenue YoY)
KRP
KRP
+3.4% gap
KRP
23.6%
20.2%
PRCT
Higher net margin
KRP
KRP
68.1% more per $
KRP
30.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
0.1%
KRP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KRP
KRP
PRCT
PRCT
Revenue
$82.5M
$83.1M
Net Profit
$24.8M
$-31.6M
Gross Margin
64.9%
Operating Margin
39.6%
-4.1%
Net Margin
30.1%
-38.1%
Revenue YoY
23.6%
20.2%
Net Profit YoY
163.2%
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRP
KRP
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$82.5M
$76.4M
Q3 25
$80.6M
$83.3M
Q2 25
$86.5M
$79.2M
Q1 25
$84.2M
$69.2M
Q4 24
$66.7M
$68.2M
Q3 24
$83.8M
$58.4M
Q2 24
$76.6M
$53.4M
Net Profit
KRP
KRP
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$24.8M
$-29.8M
Q3 25
$22.3M
$-21.4M
Q2 25
$26.7M
$-19.6M
Q1 25
$25.9M
$-24.7M
Q4 24
$-39.3M
$-18.9M
Q3 24
$25.8M
$-21.0M
Q2 24
$15.2M
$-25.6M
Gross Margin
KRP
KRP
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
KRP
KRP
PRCT
PRCT
Q1 26
-4.1%
Q4 25
39.6%
-40.6%
Q3 25
35.8%
-27.8%
Q2 25
43.7%
-28.0%
Q1 25
39.9%
-39.7%
Q4 24
-58.0%
-28.9%
Q3 24
40.8%
-38.4%
Q2 24
31.2%
-50.3%
Net Margin
KRP
KRP
PRCT
PRCT
Q1 26
-38.1%
Q4 25
30.1%
-39.1%
Q3 25
27.7%
-25.7%
Q2 25
30.8%
-24.7%
Q1 25
30.7%
-35.8%
Q4 24
-58.8%
-27.6%
Q3 24
30.8%
-35.9%
Q2 24
19.8%
-48.0%
EPS (diluted)
KRP
KRP
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRP
KRP
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$44.0M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
Total Assets
$1.2B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRP
KRP
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$44.0M
$286.5M
Q3 25
$40.0M
$294.3M
Q2 25
$34.5M
$302.7M
Q1 25
$35.6M
$316.2M
Q4 24
$34.2M
$333.7M
Q3 24
$34.7M
$196.8M
Q2 24
$30.9M
$214.1M
Total Debt
KRP
KRP
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
KRP
KRP
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$380.3M
Q2 25
$385.8M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
Total Assets
KRP
KRP
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.2B
$508.1M
Q3 25
$1.3B
$511.5M
Q2 25
$1.3B
$513.1M
Q1 25
$1.3B
$519.4M
Q4 24
$1.1B
$534.0M
Q3 24
$1.2B
$374.1M
Q2 24
$1.2B
$374.4M
Debt / Equity
KRP
KRP
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRP
KRP
PRCT
PRCT
Operating Cash FlowLast quarter
$57.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.31×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRP
KRP
PRCT
PRCT
Q1 26
Q4 25
$57.2M
$-10.3M
Q3 25
$62.8M
$-6.6M
Q2 25
$72.3M
$-15.0M
Q1 25
$54.2M
$-17.0M
Q4 24
$56.6M
$-32.4M
Q3 24
$62.4M
$-18.8M
Q2 24
$62.9M
$-15.7M
Free Cash Flow
KRP
KRP
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
KRP
KRP
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
KRP
KRP
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
KRP
KRP
PRCT
PRCT
Q1 26
Q4 25
2.31×
Q3 25
2.81×
Q2 25
2.71×
Q1 25
2.09×
Q4 24
Q3 24
2.42×
Q2 24
4.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KRP
KRP

Oil And Condensate$45.9M56%
Natural Gas Midstream$19.5M24%
NGL Revenue$10.6M13%
Other$6.4M8%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons